|
Volumn 419, Issue 6902, 2002, Pages 23-24
|
RNA as drug and antidote
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BLOOD;
DRUG PRODUCTS;
ANTIDOTES;
RNA;
ACETYLSALICYLIC ACID;
ANTICOAGULANT AGENT;
ANTIDOTE;
ANTITHROMBOCYTIC AGENT;
APTAMER;
BLOOD CLOTTING FACTOR;
BLOOD CLOTTING FACTOR 11A;
HEPARIN;
PROTAMINE;
RNA;
TICLOPIDINE;
WARFARIN;
BLOOD;
RNA;
ANTICOAGULANT THERAPY;
ANTICOAGULATION;
BASE PAIRING;
BLOOD CLOTTING;
BRAIN HEMORRHAGE;
DRUG INDUCED DISEASE;
HEART INFARCTION;
HUMAN;
INFECTION RISK;
NONHUMAN;
NUCLEOTIDE SEQUENCE;
PLASMA TRANSFUSION;
PRIORITY JOURNAL;
SHORT SURVEY;
STOMACH HEMORRHAGE;
STROKE;
VIRUS TRANSMISSION;
ANTICOAGULANTS;
ANTIDOTES;
DRUG DESIGN;
FACTOR IXA;
FACTOR VIIIA;
FACTOR X;
HEPARIN;
HEPARIN ANTAGONISTS;
HUMANS;
OLIGORIBONUCLEOTIDES;
RNA;
SUBSTRATE SPECIFICITY;
THROMBIN;
THROMBOCYTOPENIA;
|
EID: 0037026540
PISSN: 00280836
EISSN: None
Source Type: Journal
DOI: 10.1038/419023a Document Type: Short Survey |
Times cited : (7)
|
References (11)
|